ATE526414T1 - Ortsspezifische einbindung von ketoaminosäuren in proteine - Google Patents
Ortsspezifische einbindung von ketoaminosäuren in proteineInfo
- Publication number
- ATE526414T1 ATE526414T1 AT09003609T AT09003609T ATE526414T1 AT E526414 T1 ATE526414 T1 AT E526414T1 AT 09003609 T AT09003609 T AT 09003609T AT 09003609 T AT09003609 T AT 09003609T AT E526414 T1 ATE526414 T1 AT E526414T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- site
- orthogonal
- specific integration
- methods
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- -1 KETOAMINO ACIDS Chemical class 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 230000010354 integration Effects 0.000 title 1
- 108020004566 Transfer RNA Proteins 0.000 abstract 2
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 abstract 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 abstract 1
- 102000003960 Ligases Human genes 0.000 abstract 1
- 108090000364 Ligases Proteins 0.000 abstract 1
- 230000001851 biosynthetic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41926502P | 2002-10-16 | 2002-10-16 | |
| US42099002P | 2002-10-23 | 2002-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526414T1 true ATE526414T1 (de) | 2011-10-15 |
Family
ID=32110229
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09003609T ATE526414T1 (de) | 2002-10-16 | 2003-10-15 | Ortsspezifische einbindung von ketoaminosäuren in proteine |
| AT03809019T ATE429500T1 (de) | 2002-10-16 | 2003-10-15 | Stellenspezifischer einbau von ketoaminosäuren in proteine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03809019T ATE429500T1 (de) | 2002-10-16 | 2003-10-15 | Stellenspezifischer einbau von ketoaminosäuren in proteine |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US7432092B2 (de) |
| EP (2) | EP1578949B1 (de) |
| JP (1) | JP4444113B2 (de) |
| KR (1) | KR20050072441A (de) |
| AT (2) | ATE526414T1 (de) |
| AU (2) | AU2003277373B2 (de) |
| CA (1) | CA2502029C (de) |
| CY (1) | CY1110483T1 (de) |
| DE (1) | DE60327369D1 (de) |
| DK (1) | DK1578949T3 (de) |
| ES (1) | ES2324608T3 (de) |
| IL (3) | IL167715A (de) |
| MX (1) | MXPA05003983A (de) |
| PT (1) | PT1578949E (de) |
| SI (1) | SI1578949T1 (de) |
| WO (1) | WO2004035743A2 (de) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2322631T3 (en) * | 2001-04-19 | 2015-01-12 | Scripps Research Inst | Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar |
| CA2500653A1 (en) | 2002-10-16 | 2004-04-29 | The Scripps Research Institute | Glycoprotein synthesis |
| KR101171397B1 (ko) | 2003-04-17 | 2012-08-07 | 더 스크립스 리서치 인스티튜트 | 진핵 유전자 코드의 확장 |
| CA2527877A1 (en) | 2003-06-18 | 2005-01-13 | The Scripps Research Institute | Unnatural reactive amino acid genetic code additions |
| ES2301099T3 (es) * | 2003-07-07 | 2008-06-16 | The Scripps Research Institute | Composiciones de parejas ortogonales lisil-arnt y aminoacil-arnt sintetasa y usos de las mismas. |
| EP1658366A4 (de) | 2003-07-07 | 2006-08-09 | Scripps Research Inst | Zusammensetzungen von orthogonalen glutamyl-trna- und aminoacyl-trna-synthetasepaaren und deren verwendungen |
| DK1687401T3 (da) | 2003-10-14 | 2013-02-04 | Scripps Research Inst | Sted-spicifik inkorporing af redoxaktive aminosyrer i protiener |
| US8778880B2 (en) | 2004-02-02 | 2014-07-15 | Ambrx, Inc. | Human growth hormone modified at position 35 |
| MXPA06013586A (es) | 2004-05-25 | 2007-11-09 | Scripss Res Inst | Incorporacion especifica del sitio de aminoacidos no naturales que contienen atomos pesados en proteinas para la determinacion de la estructura cristalina. |
| KR101699142B1 (ko) | 2004-06-18 | 2017-01-23 | 암브룩스, 인코포레이티드 | 신규 항원-결합 폴리펩티드 및 이의 용도 |
| US7638299B2 (en) | 2004-07-21 | 2009-12-29 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| ES2666693T3 (es) | 2004-09-21 | 2018-05-07 | The Scripps Research Institute | Incorporación in vivo de alquinil aminoácidos a proteínas en eubacterias |
| WO2006036779A2 (en) * | 2004-09-22 | 2006-04-06 | The Scripps Research Institute | Site-specific labeling of proteins for nmr studies |
| WO2006045116A2 (en) | 2004-10-20 | 2006-04-27 | The Scripps Research Institute | In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria |
| WO2006110182A2 (en) * | 2004-10-27 | 2006-10-19 | The Scripps Research Institute | Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| EP2284191A3 (de) | 2004-12-22 | 2011-07-20 | Ambrx, Inc. | Prozess zur Herstellung von hGH |
| US8080391B2 (en) | 2004-12-22 | 2011-12-20 | Ambrx, Inc. | Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer |
| MX2007007590A (es) | 2004-12-22 | 2007-12-10 | Ambrx Inc | Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos. |
| WO2006071840A2 (en) | 2004-12-22 | 2006-07-06 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| WO2006068802A2 (en) | 2004-12-22 | 2006-06-29 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| CA2609205A1 (en) | 2005-06-03 | 2006-12-14 | Ambrx, Inc. | Improved human interferon molecules and their uses |
| US20090306023A1 (en) * | 2005-06-29 | 2009-12-10 | Ramirez Jose E | Stable organic peroxide compositions |
| US8367588B2 (en) * | 2005-10-12 | 2013-02-05 | The Scripps Research Institute | Selective posttranslational modification of phage-displayed polypeptides |
| US20090018029A1 (en) | 2005-11-16 | 2009-01-15 | Ambrx, Inc. | Methods and Compositions Comprising Non-Natural Amino Acids |
| ES2529065T3 (es) | 2005-12-14 | 2015-02-16 | Ambrx, Inc. | Composiciones que contienen, procedimientos que implican y usos de aminoácidos no naturales y polipéptidos |
| US7776535B2 (en) * | 2006-02-06 | 2010-08-17 | Franklin And Marshall College | Site-specific incorporation of fluorinated amino acids into proteins |
| ES2432391T3 (es) * | 2006-03-09 | 2013-12-03 | The Scripps Research Institute | Sistema para la expresión de componentes de traducción ortogonales en células huésped eubacterianas |
| BRPI0709603A2 (pt) | 2006-03-16 | 2011-07-19 | Scripps Research Inst | expressão de proteìnas geneticamente programada contendo o aminoácido não natural fenilselenocisteìna |
| CA2652894A1 (en) * | 2006-05-23 | 2007-12-06 | The Scripps Research Institute | Genetically encoded fluorescent coumarin amino acids |
| DK2615108T3 (en) | 2006-09-08 | 2017-01-30 | Ambrx Inc | Modified human plasma polypeptide or fc scaffolds and their applications |
| PT2061878E (pt) * | 2006-09-08 | 2014-04-22 | Ambrx Inc | Supressor híbrido arnt para células de vertebrados |
| DK2064333T3 (da) | 2006-09-08 | 2014-05-05 | Ambrx Inc | Suppressor-trna-transkription i hvirveldyrceller |
| EP2052083B1 (de) * | 2006-09-21 | 2014-01-08 | The Scripps Research Institute | Genetisch programmierte expression von selektiv sulfatierten proteinen in eubakterien |
| WO2008049034A1 (en) * | 2006-10-17 | 2008-04-24 | Zymera, Inc. | System for assays of aminotranferase |
| EP2069481A4 (de) | 2006-10-18 | 2010-01-06 | Scripps Research Inst | Genetischer einbau unnatürlicher aminosäuren in proteine in säugerzellen |
| GB0623974D0 (en) * | 2006-11-30 | 2007-01-10 | Medical Res Council | Evolved orthogonal ribosomes |
| PL2068909T3 (pl) | 2007-03-30 | 2012-09-28 | Ambrx Inc | Modyfikowane polipeptydy fgf-21 i ich zastosowanie |
| EP2076533B1 (de) | 2007-05-02 | 2014-10-08 | Ambrx, Inc. | Modifizierte interferon-beta-polypeptide und ihre verwendungen |
| US8946148B2 (en) | 2007-11-20 | 2015-02-03 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| US9938333B2 (en) | 2008-02-08 | 2018-04-10 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
| PL2318029T3 (pl) | 2008-07-23 | 2018-03-30 | Elanco Us Inc. | Zmodyfikowane polipeptydy bydlęcego G-CSF i ich zastosowania |
| CA2738033C (en) | 2008-09-26 | 2019-11-26 | Ambrx, Inc. | Non-natural amino acid replication-dependent microorganisms and vaccines |
| US8278418B2 (en) | 2008-09-26 | 2012-10-02 | Ambrx, Inc. | Modified animal erythropoietin polypeptides and their uses |
| WO2011073738A1 (en) | 2009-12-14 | 2011-06-23 | Metabolic Explorer | Use of inducible promoters in the production of methionine |
| BR112012015461A2 (pt) | 2009-12-21 | 2017-01-10 | Ambrx Inc | polipeptídeos de somatotropina boviina modificados e seus usos |
| US20120283172A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified porcine somatotropin polypeptides and their uses |
| EP3572091B1 (de) | 2010-08-17 | 2023-12-13 | Ambrx, Inc. | Modifizierte relaxinpolypeptide und deren verwendungen |
| US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
| AR083006A1 (es) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
| CN102888387B (zh) * | 2011-07-21 | 2015-03-18 | 中国科学院生物物理研究所 | 3-氯代酪氨酸翻译系统及其应用 |
| UY35368A (es) | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| WO2014165189A2 (en) | 2013-03-13 | 2014-10-09 | Eli Lilly And Company | Modified canine leptin polypeptides |
| US10005838B2 (en) | 2013-07-19 | 2018-06-26 | The Regents Of The University Of California | Milk fat globule epidermal growth factor 8 regulates fatty acid uptake |
| WO2015031268A1 (en) | 2013-08-26 | 2015-03-05 | Arizona Board Of Regents On Behalf Of Arizona State University | High affinity synbodies for influenza |
| US10316322B2 (en) | 2014-07-02 | 2019-06-11 | Sutro Biopharma, Inc. | High growth capacity auxotrophic Escherichia coli and methods of use |
| CN107108710B (zh) | 2014-10-24 | 2022-02-15 | 百时美施贵宝公司 | 修饰的fgf-21多肽及其用途 |
| ES2986970T3 (es) | 2014-12-04 | 2024-11-13 | Celgene Corp | Conjugados de biomoléculas |
| US9744624B2 (en) * | 2015-06-17 | 2017-08-29 | Kinsus Interconnect Technology Corp. | Method for manufacturing circuit board |
| EP3538546B1 (de) | 2016-11-14 | 2025-01-08 | Novartis AG | Zusammensetzungen, methoden und therapeutische verwendungen des fusogenen proteins minion |
| CN117860868A (zh) | 2016-11-14 | 2024-04-12 | 诺华股份有限公司 | 用于治疗软骨损伤和关节炎的方法和组合物 |
| PE20191716A1 (es) | 2017-02-08 | 2019-12-05 | Bristol Myers Squibb Co | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos |
| TW202128996A (zh) * | 2019-10-10 | 2021-08-01 | 美商史基普研究協會 | 用於活體內合成非天然多肽的組合物及方法 |
| CN120344270A (zh) | 2022-10-07 | 2025-07-18 | Ambrx 公司 | 药物接头及其抗体缀合物 |
| WO2024091824A1 (en) | 2022-10-26 | 2024-05-02 | Ada Forsyth Institute, Inc. | Differentiation and reprogramming of chondrocyte |
| KR20250134670A (ko) | 2023-01-16 | 2025-09-11 | 암브룩스, 인코포레이티드 | 항-cd70 항체-약물 접합체 |
| WO2024178310A1 (en) | 2023-02-23 | 2024-08-29 | Ambrx, Inc. | Trop2-directed antibody-drug conjugates and uses thereof |
| AR131133A1 (es) | 2023-05-24 | 2025-02-19 | Ambrx Inc | INTERFERÓN l BOVINO PEGILADO Y MÉTODOS DE USO DEL MISMO |
| WO2025041055A1 (en) | 2023-08-22 | 2025-02-27 | Ambrx, Inc. | Anti-psma adc conjugate compositions and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11504218A (ja) | 1995-04-24 | 1999-04-20 | クロマゾーム コーポレーション | 新規代謝経路の生成およびスクリーニングのための方法 |
| US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
| US5756316A (en) | 1995-11-02 | 1998-05-26 | Genencor International, Inc. | Molecular cloning by multimerization of plasmids |
| US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
| US5783431A (en) | 1996-04-24 | 1998-07-21 | Chromaxome Corporation | Methods for generating and screening novel metabolic pathways |
| DK2322631T3 (en) * | 2001-04-19 | 2015-01-12 | Scripps Research Inst | Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA syntetasepar |
| CA2500653A1 (en) * | 2002-10-16 | 2004-04-29 | The Scripps Research Institute | Glycoprotein synthesis |
-
2003
- 2003-10-15 US US10/530,421 patent/US7432092B2/en not_active Expired - Lifetime
- 2003-10-15 MX MXPA05003983A patent/MXPA05003983A/es active IP Right Grant
- 2003-10-15 DK DK03809019T patent/DK1578949T3/da active
- 2003-10-15 WO PCT/US2003/032576 patent/WO2004035743A2/en not_active Ceased
- 2003-10-15 AT AT09003609T patent/ATE526414T1/de not_active IP Right Cessation
- 2003-10-15 AU AU2003277373A patent/AU2003277373B2/en not_active Expired
- 2003-10-15 DE DE60327369T patent/DE60327369D1/de not_active Expired - Lifetime
- 2003-10-15 AT AT03809019T patent/ATE429500T1/de active
- 2003-10-15 PT PT03809019T patent/PT1578949E/pt unknown
- 2003-10-15 EP EP03809019A patent/EP1578949B1/de not_active Expired - Lifetime
- 2003-10-15 JP JP2004545280A patent/JP4444113B2/ja not_active Expired - Lifetime
- 2003-10-15 KR KR1020057006592A patent/KR20050072441A/ko not_active Ceased
- 2003-10-15 EP EP09003609A patent/EP2062976B1/de not_active Expired - Lifetime
- 2003-10-15 SI SI200331612T patent/SI1578949T1/sl unknown
- 2003-10-15 CA CA2502029A patent/CA2502029C/en not_active Expired - Lifetime
- 2003-10-15 ES ES03809019T patent/ES2324608T3/es not_active Expired - Lifetime
-
2005
- 2005-03-29 IL IL167715A patent/IL167715A/en unknown
-
2007
- 2007-10-26 US US11/978,160 patent/US7524647B2/en not_active Expired - Lifetime
- 2007-10-26 US US11/978,182 patent/US8071344B2/en not_active Expired - Lifetime
- 2007-10-26 US US11/978,140 patent/US8114629B2/en not_active Expired - Lifetime
-
2008
- 2008-08-07 US US12/228,146 patent/US7910345B2/en not_active Expired - Lifetime
-
2009
- 2009-06-24 CY CY20091100664T patent/CY1110483T1/el unknown
- 2009-07-30 AU AU2009203098A patent/AU2009203098B2/en not_active Expired
- 2009-09-29 IL IL201208A patent/IL201208A/en active IP Right Grant
-
2010
- 2010-12-29 IL IL210359A patent/IL210359A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526414T1 (de) | Ortsspezifische einbindung von ketoaminosäuren in proteine | |
| WO2005038002A3 (en) | Site-specific incorporation of redox active amino acids into proteins | |
| ATE541934T1 (de) | Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon | |
| EP1704242A4 (de) | ZUSAMMENSETZUNGEN MIT PAAREN VON ORTHOGONALER LEUCYL-tRNA UND AMINOACYL-tRNA-SYNTHETASE UND VERWENDUNGEN DAVON | |
| IL158419A (en) | Cell containing orthogonal trna synthase (ors) and orthogonal trna (otrna) | |
| WO2005007624A3 (en) | Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof | |
| ATE386133T1 (de) | Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen | |
| EP1613735A4 (de) | Ausweitung des eukaryotischen genetischen codes | |
| WO2006034410A3 (en) | Adding photoregulated amino acids to the genetic code | |
| ATE542888T1 (de) | Standortspezifische inkorporation nicht natürlicher aminosäuren in wirbeltierzellen | |
| BRPI0411475A (pt) | adições de código genético de aminoácido reativo não natural | |
| MX2007003142A (es) | Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias. | |
| ATE381623T1 (de) | Verfahren zur expression von protein mit darin integrierter unnatürlicher aminosäure | |
| EP1914314A3 (de) | Zusammensetzungen aus orthogonalen Lysyl-TRNA- und Aminoacyl-TRNA-Synthetasepaaren und deren Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |